Answers are grounded in this paper and cite their sources.
Background: Donnai-Barrow/facio-oculu-acoustico-renal syndrome (DBS) is a hereditary multisystem disease in which renal involvement is characterized by low molecular weight (LMW) proteinuria.It is caused by pathogenic variants in the gene encoding Megalin , a multi-ligand receptor that plays a crucial role in LMW proteins absorption.To date, 32 patients have been described.There is no definitive treatment for this rare condition at this time.Case-diagnosis: We present two brothers who exhibit mild facial dysmorphism, severe hearing and vision impairment and mild renal dysfunction with LMW proteinuria.They initial presumed diagnosis was Alport syndrome; however, a final diagnosis of DBS was made by whole exome sequencing (WES).Both patients harbor two distinct novel mutations in LPR2, each inherited from one parent.Conclusion: Early recognition and molecular diagnosis of DBS is essential, in order to improve family education and guide treatment interventions.These include cardiac, neurologic, ophthalmologic, audiologic and renal examinations and monitoring.Prenatal and pre-implantation genetic screening should be offered to these families.In addition, special attention is emphasized for low molecular weight proteinuria in young patients.
No takes yet. Share an insight, caveat, or question.
Angel-Korman et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: